GRIFOLS | GRF - Koszty Sprzedaży I Administracji





Koszty Sprzedaży I Administracji Zmiana Data
Alcon AG USD 964M 82M 2026-06
Amadeus IT EUR 497.5M 206.6M 2025-03
Amarin USD 18.97M 1.03M 2025-12
argenx SE USD 417M 62M 2026-06
AstraZeneca USD 5.8B 735M 2026-06
Bayer EUR 3.96B 267M 2026-06
Cie Automotive EUR 315.66M 28.06M 2024-12
Demant DKK 7.09B 1B 2026-06
Ence Energia y Celulosa EUR 29.1M 2M 2024-09
Essilor EUR 5.75B 139M 2026-06
Ferrovial EUR 906M 52M 2024-12
Fresenius EUR 760M 17M 2026-06
Fresenius Medical Care EUR 736.01M 12.99M 2026-06
Genmab DKK 205M 39M 2026-06
GlaxoSmithKline GBP 2.19B 75M 2026-06
GRIFOLS EUR 289M 8M 2026-06
Hikma Pharmaceutical USD 288M 149M 2025-12
Inditex EUR 2.51B 7.98B 2025-01
Lakefront Biotherapeutics EUR 22.5M 13M 2026-06
Merck EUR 1.57B 49M 2026-06
Novartis USD 3.24B 101M 2026-06
Philips EUR 1.21B 23M 2026-06
Roche Holding CHF 6.37B 908M 2026-06
Sanofi EUR 2.63B 307M 2026-06
Smith & Nephew USD 1.45B 29M 2026-06
UCB EUR 1.47B 193M 2025-12
Viscofan EUR 72.59M 4.52M 2025-03